longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Hims & Hers Health

HIMS

27.8503.33% ( -0.960 )
Closed: Sep 15, 16:00:00 (EDT)
Start trading
OverviewOverviewOptionsOptionsNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is -47.33, within the reasonable range, cheaper than 66.62% of the time in the past 3 years, and the industry ranks 58/74, the industry Median --.

-47.33xP/E
$28.81Stock price
$-0.61Earnings per share
-47.33xP/E
Stock price$28.81Earnings per share$-0.61

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
47.50x
Typical range
-129.20x–68.10x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
07142128

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x40x80x120x160x200x
P/E ratio
Name/Symbol
GHUSGuardant Health
-49.67x2.92%$22.52B
HIMSUSHims & Hers Health
-47.33x209.86%$6.72B
RDNTUSRadnet
-281.34x128.00%$5.94B
WGSUSGeneDx
-25.16x359.59%$2.68B
NEOUSNeogenomics
-45.59x64.73%$2.37B
AGLUSagilon health
-6.68x93.07%$1.55B
INNVUSInnovage
-579.26x2,300.00%$1.47B
OPKUSOpko Health
-15.97x25.44%$1.16B
LMRIUSLumexa Imaging
-39.46x146.66%$1.09B
CSTLUSCastle Biosciences
-52.62x53.28%$1.02B
GMRSUSGMR Solutions
-9.47x91.45%$716.33M
FLGTUSFulgent Genetics
-6.73x42.64%$568.19M
PREUSPrenetics Global
-8.80x19.04%$413.50M
AONCUSAmerican Oncology Network
----$371.06M
BDSXUSBiodesix
-10.41x42.77%$289.10M
AIRSUSAirSculpt Tech
-14.62x33.33%$171.59M
NAKAUSNakamoto
-0.35x101.83%$146.92M
GAMGUSGlobal Asset Management Group, Inc.
-226.07x--$127.60M
CORBFUSGlobal Cord Blood Corporation
----$127.35M
PARKUSPark Dental Partners
-28.53x--$100.86M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.